Hsbc Holdings PLC Moderna, Inc. Put Options Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $2.01 Million - $2.72 Million	-23,600 Reduced 41.26%	33,600 $3.58 Million
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $472,668 - $710,124	-6,800 Reduced 10.63%	57,200 $5.69 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $2.59 Million - $3.41 Million	26,900 Added 72.51%	64,000 $6.61 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $1.6 Million - $2.17 Million	13,500 Added 57.2%	37,100 $4.51 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.79 Million - $4.58 Million	23,600 New	23,600 $2.84 Million

928

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.